16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Out-of-pocket expenditure due to hepatitis A disease: A study from Kollam district, Kerala, India

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Several outbreaks of hepatitis A have been reported from Kerala, India, in the last 10 years1 2 3 4. An average of 8268 [standard deviation (SD) 1767] cases suspected to have hepatitis A per year has been reported to the State's official disease surveillance system4 5. Most of the affected individuals were young adults between 15 and 35 yr age group. Many public health experts have opined that the Government should start thinking of hepatitis A vaccination in Kerala6 7. Cost is considered as a major concern by many for recommending hepatitis A vaccine in the State. Knowing the out-of-pocket expenditure due to hepatitis A will help the policymakers to decide on the vaccination policy in the State. The present study was done in Kollam district of Kerala in 2015 to estimate the out-of-pocket expenditure experienced by households due to hepatitis A disease. Kollam district with a population of around 2.6 million has reported maximum number of hepatitis A cases in the State4 5. The female literacy rate for the district is 92 per cent8. Integrated disease surveillance programme (IDSP) has been performing reasonably well in the district with the help of a good primary health care team and notifications from major private hospitals. Apart from IDSP weekly reporting, the State also depends on a daily telephone-based reporting system, which collects information regarding communicable diseases from all the government hospitals on a daily basis. The District Surveillance Unit (DSU) prepares a line list of affected people for major communicable diseases based on information from daily and weekly reports. The district reported 584 cases of hepatitis A during 2015. Line list of people affected with hepatitis A notified to the DSU during August-October 2015 (n=114) was obtained. All 114 individuals with confirmed hepatitis A were contacted with the help of primary health care team. Exploratory interview, using a pretested and validated questionnaire, was conducted during November 2015-January 2016, with the selected participants at their houses. Details of cost during hospitalization, consultation fees to doctors including traditional healers, amount spent on drugs including traditional medicines, laboratory investigations, additional amount spent for food and travel due to illness by the patient and relatives, informal tips, payment to caregivers, wages lost due to sickness for the patient and wage loss to any relative were collected in detail. Bills and medical records available with the patients were verified. The study was approved by Ethics committee of Center for Public Health Protection, Kollam (6/2015 dated 15.06.15). For assessing the indirect cost, only the actual income loss to patient and relatives was considered. The productivity loss due to forgone non-market activities including school, household works and intangible cost was not converted to monitory terms. Data were analyzed using SPSS version 12 (SPSS, Chicago, IL, USA). Data were presented as a total and as an average with a SD in local currency, i.e., Indian Rupees () and US dollars (US$) applying the exchange rate (US$1=68). A total of 95 of 114 patients were interviewed. Others could not be contacted (n=6) or were not available at the address provided (n=13) during the data collection period. Among them, 40 per cent (n=38) were less than 15 yr, 47.4 per cent (n=45) were between 16 and 30 yr and 10.5 per cent (n=10) were between 31 and 45 yr. Males constituted 60 per cent (n=57). Of them, 60 per cent (n=57) were students, 16.8 per cent (n=16) were unskilled/semi-skilled labourers, 6.3 per cent (n=6) were homemakers, 4.2 per cent (n=4) were professionals/semi-professionals, 3.2 per cent (n=3) were skilled labourers and 2.1 (n=2) per cent were doing petty business. Further, 78.9 per cent (n=75) of the household interviewed possessed a below poverty line card. Of the 95 patients, 79 (83.2 %) had hospital admission, and 77.1 per cent (61/79) had admissions in government hospitals. The mean number of days admitted in hospital was 7.60 (standard error 0.92), median being four days. Of them (n=95), 30.6 per cent (n=29) consulted only modern medicine doctors, 18.9 per cent (n=18) consulted Ayurveda system, 6.3 per cent (n=6) visited traditional healers while 44.2 per cent (n=42) visited practitioners from more than one system. The median work days lost due to illness was 60 (range 21-180 days). The details of amount spent for each purpose and the total out-of-pocket expenditure (OOPE) are given in Table I. The mean direct medical cost, direct non-medical cost and indirect costs were 8446.2 (95% confidence interval (CI) 6726.1-10,166.3], 4438.1 (95% CI 3502.1-5374.2) and 11890.5 (6762.2-17,018.4), respectively. Total OOPE for the households due to one of its members affected with hepatitis A disease in Kollam district was 24,774.8 (95% CI 19426.3- 30,123.2) (364 US$) with a median expenditure of 17,700 (260 US$). Table I Details of household out-of-pocket expenditure due to hepatitis A disease in Kollam district, Kerala The details of OOPE by various categories are given in Table II. The OOPE due to hepatitis A disease was higher among those who sought care in modern medicine, especially from private sector. Table II Details of out-of-pocket expenditure (OOPE) due to hepatitis A by various categories In our study 34 per cent of total OOPE was found to be contributed by direct medical expenses while nearly 47 per cent was due to indirect expenditures. Majority of the patients were students and hence not working. The period of absence in schools and year lost due to missing examinations were not converted to monitory terms in the current study. Capturing the health system costs due to hepatitis A which includes service and material costs at government hospitals and cost of public health interventions to deal with hepatitis A cases will give the true picture of the economic loss due to hepatitis A disease. It should also be noted that the indirect costs of health care also contribute to the financial burden incurred by households. There could be some recall bias as data were collected after receiving treatment. However, to minimize the bias, we conducted all interviews between three and four months after initial diagnosis. Sample size was small limiting the ability to look at sub-groups and interactions. The official disease surveillance system has its own weaknesses that it may miss many hepatitis A cases. The HAV antibody seroprevalence rates reported from Kerala was <10 per cent in children below five years when compared to 60-80 per cent from many other parts of the country9 10 11. Among the Indian States, Kerala has the highest average out-of-pocket healthcare spending share and there is very little variation in this share across consumption expenditure quintiles12. We could not find any recent studies on OOPE due to hepatitis A from India; however, the OOPE in the current study seemed very high when compared with the same estimated by other studies for other communicable diseases such as tuberculosis under DOTS from Chennai and acute illness including hospitalizations from Puduchery13 14. The OOPE for those who sought treatment from private sector was high in this study, and this result was consistent with other study reports from India15. To conclude, the average household OOPE due to one of its members affected with hepatitis A disease in Kollam district was around 25,000. Directions for future research include assessing the real burden of hepatitis A and detailed economic analysis of universalizing HAV vaccination in the State.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Economic and Disease Burden of Dengue Illness in India

          Between 2006 and 2012 India reported an annual average of 20,474 dengue cases. Although dengue has been notifiable since 1996, regional comparisons suggest that reported numbers substantially underrepresent the full impact of the disease. Adjustment for underreporting from a case study in Madurai district and an expert Delphi panel yielded an annual average of 5,778,406 clinically diagnosed dengue cases between 2006 and 2012, or 282 times the reported number per year. The total direct annual medical cost was US$548 million. Ambulatory settings treated 67% of cases representing 18% of costs, whereas 33% of cases were hospitalized, comprising 82% of costs. Eighty percent of expenditures went to private facilities. Including non-medical and indirect costs based on other dengue-endemic countries raises the economic cost to $1.11 billion, or $0.88 per capita. The economic and disease burden of dengue in India is substantially more than captured by officially reported cases, and increased control measures merit serious consideration.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Investigating a Community-Wide Outbreak of Hepatitis A in India

            Background: There was an outbreak of acute hepatitis in Mylapore village, Kollam district, Kerala, southern India during February to June 2013. An outbreak investigation was initiated with the objective of describing the epidemiological features of the hepatitis outbreak. Materials and Methods: House-to-house visits were undertaken to identify symptomatic cases. The outbreak was described in terms of person, place and time. Hypothesis was generated based on findings from descriptive study, laboratory investigation of water samples, and environmental observations. A case-control study was designed to test the hypothesis. Chi-square test, univariate analysis, and logistic regression to identify the risk factors associated with hepatitis A infection were done. Results: Line list generated consisted of 45 cases. Attack rate was the highest among the age group 15-24 years (4.6%) followed by 5-14 years (3.1%). The geographical distribution of the cases suggested a clustering around the water supply through the pipeline and epidemic curve showed a sharp rise in cases suggestive of a common source outbreak. Water samples collected form pipeline showed evidence of fecal contamination and absence of residual chlorine. In the case-control study, having consumed water from the pipeline (odds ratio: 9.01 [95% confidence interval: 2.16-37.61]) was associated with the hepatitis A cases. Conclusion: The time frame of disease occurrence, environmental observations, anecdotal evidences, laboratory results and results of the analytical study indicated the possibility of occurrence of hepatitis A outbreak as a result of pipe water contamination supplied from a bore well. The study warrants establishment of an efficient water quality surveillance system.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Viral Hepatitis Surveillance — India, 2011–2013

              The burden of viral hepatitis in India is not well characterized. In 2009, the national Integrated Disease Surveillance Programme (IDSP) began conducting surveillance across all Indian states for epidemic-prone diseases, including foodborne and waterborne forms of viral hepatitis (e.g., hepatitis A and E). Information on outbreaks of all forms of viral hepatitis, including A, B, C, and E, also is collected. This report summarizes viral hepatitis surveillance and outbreak data reported to IDSP during 2011–2013. During this period, 804,782 hepatitis cases and 291 outbreaks were reported; the virus type was unspecified in 92% of cases. Among 599,605 cases tested for hepatitis A, 44,663 (7.4%) were positive, and among 187,040 tested for hepatitis E, 19,508 (10.4%) were positive. At least one hepatitis outbreak report was received from 23 (66%) of 35 Indian states. Two-thirds of outbreaks were reported from rural areas. Among 163 (56%) outbreaks with known etiology, 78 (48%) were caused by hepatitis E, 54 (33%) by hepatitis A, 19 (12%) by both hepatitis A and E, and 12 (7%) by hepatitis B or hepatitis C. Contaminated drinking water was the source of most outbreaks. Improvements in water quality and sanitation as well as inclusion of hepatitis A vaccine in childhood immunization programs should be considered to reduce the public health burden of hepatitis in India. Efforts to decrease the proportion of cases for which the etiology is unspecified, including expanding the IDSP to support hepatitis B and C testing, might help further elucidate the epidemiology of these diseases. India is known to have a large burden of viral hepatitis (1–4), but national surveillance data are lacking. In 2009, IDSP, operated through India’s National Center for Disease Control (NCDC), became active in all Indian states (5). Weekly surveillance data on 18 epidemic-prone diseases, including viral hepatitis, are collected through this program. All 28,850 government-run primary health care centers and hospitals and 2,923 designated private facilities serve as reporting units, which collect and report data on hepatitis cases (any acute onset of jaundice) and outbreaks, and report them to district surveillance units each week. These reports are submitted as aggregate data to IDSP through a web portal ( http://www.idsp.nic.in ); no demographic information, risk factors, or other data are collected or reported. The district surveillance units also investigate suspected hepatitis outbreaks (two or more epidemiologically linked cases of acute jaundice). IDSP supports testing for hepatitis A and E, and during outbreaks, testing for hepatitis B and C also is supported. Outbreak investigation reports include a description of the affected population, number of cases and deaths, date of onset of the first case, laboratory data, information on the suspected source of the outbreak, and control measures undertaken. Hepatitis outbreaks are classified by etiology when at least one case is laboratory-confirmed and the others are epidemiologically linked. Cases are categorized as hepatitis A, B, C, E, or unspecified if the etiology is not determined. NCDC operates a national outbreak-monitoring call center and a national media scanning center to identify suspected outbreaks and, after investigation, also compiles them into weekly national alerts. This report summarizes an analysis of 2011–2013 national viral hepatitis surveillance and outbreak data from IDSP and weekly national alerts. Census data from 2011 were used to calculate incidence. During 2011–2013, a total of 804,782 viral hepatitis cases were reported to IDSP. Among 599,605 (74.5%) cases tested for hepatitis A, 44,663 (7.4%) were positive, and among 187,040 (23.2%) tested for hepatitis E, 19,508 (10.4%) were positive. The etiology of 740,611 (92%) reported cases was not determined (Figure 1 and Figure 2). During June–September of each reporting year, a 17% increase in the total number of reported hepatitis cases above baseline was observed, and laboratory-confirmed hepatitis A cases followed the same seasonal pattern with an average increase of 18% (Figure 2). During the 3-year period, eight states had average annual rates of >50/100,000 total hepatitis cases, whereas no state reported rates of ≥10/100,000 hepatitis A or E cases during any year of the reporting period. During the 3-year period, 291 hepatitis outbreaks involving 15,601 cases and 58 (4%) deaths were reported to IDSP. Outbreak-related cases accounted for 1.9% of all reported hepatitis cases. Twenty-three (65.7%) of India’s 35 states reported at least one hepatitis outbreak; five states reported >20 outbreaks (Figure 3). More outbreaks were reported from rural areas (199 [68%]) than urban areas (92 [32%]); 163 (56%) outbreaks were laboratory-confirmed, and, of those, most were either hepatitis E (78 [47.9%]) or hepatitis A (54 [33.1%]). Additionally, both hepatitis A and E were reported in 19 outbreaks, and hepatitis B or C, or both, was reported as the etiology of 12 outbreaks. Contaminated drinking water was identified as a cause for 72% (109 of 151) of the hepatitis A and E outbreaks, and was implicated in 49 (38%) of the 128 outbreaks for which laboratory confirmation was not available. Discussion This is the first report of national viral hepatitis surveillance and outbreak data from India. Although a specific etiology was not confirmed for most reported cases, hepatitis cases and outbreaks caused by hepatitis A and E were regularly reported from most regions, and a seasonal variation in hepatitis A cases was recognized, although no seasonal pattern was observed for outbreaks. Consistent with previous reports from India (1,2), unsafe drinking water was the most commonly reported cause of hepatitis A and E outbreaks, highlighting the need for improved access to clean drinking water and improved sanitation. Although IDSP does not routinely support laboratory testing for hepatitis B and C, it does support testing during outbreaks, resulting in some hepatitis B and C outbreaks being detected. This finding suggests a potential benefit of including hepatitis B and C testing of nonoutbreak cases reported to IDSP to better understand the burden and epidemiology of these pathogens. The small proportion of jaundice cases tested for either hepatitis A or E that tested positive, 7% and 10%, respectively, needs further investigation. The low number of laboratory-confirmed cases could be the result of misclassification of clinical cases, laboratory error, delays in testing, or large numbers of acute hepatitis that are neither A nor E. Some states with the highest reported number of outbreaks were among those supported by the World Bank for surveillance infrastructure strengthening (6), and better surveillance in these states might account for the increased number of cases as well as outbreaks reported, rather than an actual greater number of outbreaks in these states. Surveillance for hepatitis often underestimates the actual number of cases. Nevertheless, IDSP identified a substantial number of hepatitis cases and outbreaks during 2011–2013. The large number of hepatitis A and E outbreaks might be explained in part by the lack of adequate sewage and sanitation systems (1); defecation in open fields, which can contaminate surface drinking-water sources, remains a common practice. The large numbers of hepatitis A cases might also reflect an epidemiologic shift in the affected population in India. Hepatitis A infection during childhood often is asymptomatic and unrecognized, and typically confers lifelong immunity. With increasing age at time of infection, symptomatic cases become more common. With improved hygiene and sanitation reflecting India’s improving economy, more children might escape childhood infection and remain susceptible to infection during adolescence and adulthood (7). Demographic data, including age, not currently included in IDSP, would help to better understand the epidemiology of hepatitis A in India. Such data also could be used to inform consideration of inclusion of hepatitis A vaccine in the routine immunization program. Peaks in reporting occurred during the monsoon season (June–September) for both total cases reported and hepatitis A cases reported during each of the reporting years. This pattern suggests that most unspecified cases might be hepatitis A, and that there is seasonal variation in transmission of hepatitis A, possibly related to contamination of drinking water during periods of heavy rain. Hepatitis B and C cause substantial morbidity and mortality worldwide. Although poorly described in India, hepatitis B and C are thought to contribute substantially to the country’s overall hepatitis burden (3,4). Through IDSP, laboratory support has been steadily strengthened, and most states have at least one public health laboratory (5,6); however, routine laboratory testing of suspected hepatitis cases for hepatitis B and C is not currently supported by IDSP. Inclusion of such testing would improve understanding of the epidemiology of hepatitis B and C and relevant risk factors. Further, surveillance for chronic hepatitis, cirrhosis, and hepatocellular carcinoma would give valuable insights into the long-term disease burden in the country (2). The findings in this report are subject to at least four limitations. First, the finding that more hepatitis outbreaks are reported from rural than urban areas might partially be explained by greater government-sponsored health care delivery in rural areas, which might be more likely to identify and report outbreaks to IDSP. Second, the majority of reported cases were not laboratory-confirmed. Third, data were available for only a few hepatitis B and C outbreaks, limiting the use of data from those investigations. Finally, incomplete follow-up and reporting of outbreaks to IDSP might lead to an underestimation of the burden and an inadequate understanding of the epidemiology of the outbreaks. Routine disease surveillance is a core public health function. The formation of IDSP is a major advance toward building India’s public health capacity to identify and react to urgent threats and monitor disease trends. Hepatitis surveillance data obtained through IDSP can be used to monitor disease trends, identify local hepatitis outbreaks, and to evaluate the effectiveness of sanitation, safe water, immunization, and other prevention and control measures. To enhance the utility of its data, IDSP might consider introducing case-based surveillance that includes demographic and risk factor data, improving geographic representativeness of surveillance data, and increasing the proportion of cases that are laboratory-confirmed. Further, increasing laboratory capacity to include hepatitis B and C into routine testing might help identify unrecognized modes of transmission and populations at risk for infection (4). Summary What is already known on this topic? Hepatitis A and hepatitis E are endemic in India, and although hepatitis B and hepatitis C are thought to be common, national data are lacking on all forms of viral hepatitis. What is added by this report? The National Integrated Disease Surveillance Program, established in India in 2009, collects data on cases and outbreaks of jaundice, and supports outbreak investigations and laboratory testing for hepatitis A and hepatitis E. During 2011–2013, large numbers of hepatitis A and hepatitis E cases and frequent outbreaks occurred each year. Hepatitis A and hepatitis E outbreaks were reported throughout the country, associated with poor water quality and lack of sanitation. Cases of hepatitis A appeared to follow a seasonal pattern associated with the monsoon season. What are the implications for public health practice? Epidemiologic and laboratory strengthening of the Integrated Disease Surveillance Program might improve understanding of the hepatitis disease burden in India because most cases were not laboratory-confirmed. Further, the large numbers of cases and outbreaks underscore the need for improvements in water quality and sanitation. Finally, collection of additional demographic and epidemiologic data on hepatitis A can inform consideration of including hepatitis A vaccine in routine immunization programs.
                Bookmark

                Author and article information

                Journal
                Indian J Med Res
                Indian J. Med. Res
                IJMR
                The Indian Journal of Medical Research
                Medknow Publications & Media Pvt Ltd (India )
                0971-5916
                September 2017
                : 146
                : 3
                : 426-429
                Affiliations
                [1 ]Centre for Public Health Protection, Kollam, Kerala, India
                [2 ]Department of Community Medicine, Travancore Medical College, Kollam, Kerala, India
                Author notes
                [* ] For correspondence: epidklm@ 123456gmail.com
                Article
                IJMR-146-426
                10.4103/ijmr.IJMR_275_16
                5793480
                29355152
                504410b3-b27f-4ff3-a4ce-ba49eb3f503e
                Copyright: © 2017 Indian Journal of Medical Research

                This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

                History
                : 21 February 2016
                Categories
                Correspondence

                Medicine
                Medicine

                Comments

                Comment on this article